Mimetic Medicines is developing a pipeline of novel, long-acting, non-opioid drug candidates for chronic pain
Mimetic Medicines is developing a pipeline of novel, long-acting, non-opioid drug candidates for chronic pain. Mimetic’s drug candidates take advantage of the company’s proprietary short lipidated peptide (“SLiP”) platform to target ion channel / scaffold protein complexes that become dysregulated in patients with chronic pain.